207 related articles for article (PubMed ID: 12768271)
21. Ethical considerations in psychopharmacological research involving decisionally impaired subjects.
Rosenstein DL; Miller FG
Psychopharmacology (Berl); 2003 Dec; 171(1):92-7. PubMed ID: 12774188
[TBL] [Abstract][Full Text] [Related]
22. Informed consent and ethical reporting of research in clinical trials involving participants with psychotic disorders.
Weissinger GM; Ulrich CM
Contemp Clin Trials; 2019 Sep; 84():105795. PubMed ID: 31247285
[TBL] [Abstract][Full Text] [Related]
23. Changes in capacity to consent over time in patients involved in psychiatric research.
Palmer BW; Savla GN; Roesch SC; Jeste DV
Br J Psychiatry; 2013 Jun; 202(6):454-8. PubMed ID: 23661766
[TBL] [Abstract][Full Text] [Related]
24. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
Vanderpool HY
Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
[TBL] [Abstract][Full Text] [Related]
25. Recall of informed consent information by healthy volunteers in clinical trials.
Fortun P; West J; Chalkley L; Shonde A; Hawkey C
QJM; 2008 Aug; 101(8):625-9. PubMed ID: 18487271
[TBL] [Abstract][Full Text] [Related]
26. Assessing decisional capacity for research participation in psychiatric patients and their relatives.
George DE; Dholakia S; Tharyan P
Indian J Med Ethics; 2018; 3(2):125-133. PubMed ID: 28918381
[TBL] [Abstract][Full Text] [Related]
27. Capacity to consent to research participation in adults with malignant glioma.
Marson DC; Martin RC; Triebel KL; Nabors LB
J Clin Oncol; 2010 Aug; 28(24):3844-50. PubMed ID: 20644102
[TBL] [Abstract][Full Text] [Related]
28. Informed consent in schizophrenia: the use of cues in the assessment of understanding.
Combs DR; Adams SD; Wood TD; Basso MR; Gouvier WD
Schizophr Res; 2005 Sep; 77(1):59-63. PubMed ID: 16005385
[TBL] [Abstract][Full Text] [Related]
29. Improved pregnant women's understanding of research information by an enhanced informed consent form: a randomised controlled study nested in neonatal research.
Koonrungsesomboon N; Traivaree C; Chamnanvanakij S; Rungtragoolchai P; Thanapat Y; Karbwang J
Arch Dis Child Fetal Neonatal Ed; 2018 Sep; 103(5):F403-F407. PubMed ID: 28818850
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.
Stroup TS; Appelbaum PS; Gu H; Hays S; Swartz MS; Keefe RS; Kim SY; Manschreck TC; Boshes RA; McEvoy JP; Lieberman JA
Schizophr Res; 2011 Aug; 130(1-3):47-52. PubMed ID: 21561740
[TBL] [Abstract][Full Text] [Related]
31. Ethical issues in schizophrenia: considerations for treatment and research.
Dunn LB
Psychopharmacol Bull; 2007; 40(4):145-55. PubMed ID: 18227784
[TBL] [Abstract][Full Text] [Related]
32. Decisional Capacity to Consent to Clinical Research Involving Placebo in Psychiatric Patients.
Parmigiani G; Mandarelli G; Dacquino C; Pompili P; Lelli Chiesa G; Ferracuti S
J Forensic Sci; 2016 Mar; 61(2):388-393. PubMed ID: 27404612
[TBL] [Abstract][Full Text] [Related]
33. Volunteer experiences and perceptions of the informed consent process: Lessons from two HIV clinical trials in Uganda.
Ssali A; Poland F; Seeley J
BMC Med Ethics; 2015 Dec; 16(1):86. PubMed ID: 26630924
[TBL] [Abstract][Full Text] [Related]
34. Capacity to provide informed consent among adults with bipolar disorder.
Klein CC; Jolson MB; Lazarus M; Masterson B; Blom TJ; Adler CM; DelBello MP; Strakowski SM
J Affect Disord; 2019 Jan; 242():1-4. PubMed ID: 30153563
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of patient comprehension of informed consent.
Crepeau AE; McKinney BI; Fox-Ryvicker M; Castelli J; Penna J; Wang ED
J Bone Joint Surg Am; 2011 Oct; 93(19):e114(1-7). PubMed ID: 22005875
[TBL] [Abstract][Full Text] [Related]
36. What do people at risk for Alzheimer disease think about surrogate consent for research?
Kim SY; Kim HM; McCallum C; Tariot PN
Neurology; 2005 Nov; 65(9):1395-401. PubMed ID: 16275826
[TBL] [Abstract][Full Text] [Related]
37. Competence to consent to research among long-stay inpatients with chronic schizophrenia.
Kovnick JA; Appelbaum PS; Hoge SK; Leadbetter RA
Psychiatr Serv; 2003 Sep; 54(9):1247-52. PubMed ID: 12954941
[TBL] [Abstract][Full Text] [Related]
38. Acceptance and insight: incapacity to give informed consent.
van Staden WC
Curr Opin Psychiatry; 2009 Nov; 22(6):554-8. PubMed ID: 19696676
[TBL] [Abstract][Full Text] [Related]
39. [Informed consent as viewed by patients participating in cardiology drug trial].
Meneguin S; Zoboli EL; Domingues RZ; Nobre MR; César LA
Arq Bras Cardiol; 2010 Jan; 94(1):4-9. PubMed ID: 20414520
[TBL] [Abstract][Full Text] [Related]
40. Next generation sequencing in psychiatric research: what study participants need to know about research findings.
Mathieu G; Groisman IJ; Godard B
Int J Neuropsychopharmacol; 2013 Oct; 16(9):2119-27. PubMed ID: 23725748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
